Takaaki Murakami Selected Research

Takaaki Murakami Research Topics

Disease

5	Neoplasms (Cancer) 01/2022 - 04/2015
5	Type 2 Diabetes Mellitus (MODY) 01/2021 - 01/2015
5	Insulinoma 01/2021 - 12/2017
5	Hypoglycemia (Reactive Hypoglycemia) 10/2020 - 01/2015
4	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 04/2017
4	Polyps 01/2022 - 06/2017
4	Diabetes Mellitus 01/2021 - 01/2016
3	Constipation 02/2022 - 01/2020
2	Nausea 02/2022 - 10/2020
2	Hyperglycemia 05/2020 - 01/2015
2	Hemorrhage 01/2019 - 03/2003
2	MELAS Syndrome (Syndrome, MELAS) 01/2016 - 01/2016
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2016 - 01/2016
1	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 05/2022
1	Pain (Aches) 02/2022
1	Chronic Pain 02/2022
1	Respiratory Insufficiency (Respiratory Failure) 02/2022
1	Fatigue 02/2022
1	Pituitary Diseases (Disease, Anterior Pituitary) 02/2022
1	Adrenal Insufficiency (Adrenal Gland Hypofunction) 02/2022
1	Abdominal Pain (Pain, Abdominal) 02/2022
1	Disease Progression 02/2022
1	Insulin Resistance 01/2022
1	Hyponatremia 02/2021
1	Acromegaly 01/2021
1	Pituitary Neoplasms (Pituitary Adenoma) 01/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2020
1	Drug-Related Side Effects and Adverse Reactions 05/2020
1	Glucose Intolerance 12/2019
1	Thromboembolism 01/2019
1	Stomach Neoplasms (Stomach Cancer) 01/2018
1	Colonic Neoplasms (Colon Cancer) 01/2018
1	Intestinal Diseases (Diseases, Intestinal) 12/2017
1	Epilepsy (Aura) 12/2017
1	Seizures (Absence Seizure) 12/2017
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2017
1	Inappropriate ADH Syndrome (SIADH) 01/2017
1	Stupor 01/2017
1	Postoperative Hemorrhage 08/2016
1	Cognitive Dysfunction 01/2016
1	Adenocarcinoma 01/2015
1	Lung Neoplasms (Lung Cancer) 01/2015

Drug/Important Bio-Agent (IBA)

5	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2015
4	Hypoglycemic Agents (Hypoglycemics)IBA 01/2021 - 01/2016
3	AnticoagulantsIBA 01/2022 - 08/2016
2	Pharmaceutical PreparationsIBA 01/2022 - 05/2020
2	Deamino Arginine Vasopressin (Desmopressin)FDA LinkGeneric 02/2021 - 01/2014
2	SodiumIBA 02/2021 - 01/2017
2	Exenatide (Byetta)FDA Link 01/2021 - 01/2021
2	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 01/2021 - 01/2020
2	Insulin Glargine (Lantus)FDA Link 01/2016 - 01/2015
1	Volatile Fatty AcidsIBA 05/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2022
1	Corticotropin-Releasing HormoneIBA 02/2022
1	Fentanyl (Sublimaze)FDA LinkGeneric 02/2022
1	Opioid Analgesics (Opioids)IBA 02/2022
1	Morphine (MS Contin)FDA LinkGeneric 02/2022
1	Dasatinib (BMS 354825)FDA Link 01/2022
1	QuercetinIBA 01/2022
1	Growth Hormone (Somatotropin)IBA 01/2021
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 11/2020
1	CalciumIBA 10/2020
1	alectinibIBA 05/2020
1	CrizotinibIBA 05/2020
1	Anaplastic Lymphoma KinaseIBA 05/2020
1	ceritinibIBA 05/2020
1	Calcium Gluconate (CBG)IBA 03/2020
1	Blood Glucose (Blood Sugar)IBA 03/2020
1	ElectrolytesIBA 01/2020
1	elobixibatIBA 01/2020
1	CanagliflozinIBA 12/2019
1	firuglipelIBA 12/2019
1	GTP-Binding Proteins (G-Protein)IBA 12/2019
1	MucinsIBA 12/2017
1	Carbon DioxideIBA 01/2017
1	Vasopressins (Vasopressin)IBA 01/2017
1	Leu Transfer RNAIBA 01/2016
1	Glucagon-Like Peptide-1 ReceptorIBA 01/2016
1	Biological ProductsIBA 01/2016
1	Biomarkers (Surrogate Marker)IBA 01/2016
1	Growth Differentiation Factor 15IBA 01/2016
1	fibroblast growth factor 21IBA 01/2016
1	Insulin (Novolin)FDA Link 01/2016
1	Mitochondrial DNA (mtDNA)IBA 01/2016
1	Liraglutide FDA Link 01/2016
1	Amyloid (Amyloid Fibrils)IBA 04/2015
1	LigandsIBA 01/2015

Therapy/Procedure

7	Therapeutics 02/2022 - 08/2002
6	Lasers (Laser) 01/2022 - 06/2017
3	Glycemic Control 01/2016 - 01/2015
2	Endoscopes 05/2020 - 01/2019
1	Drug Tapering 02/2022
1	Traction 11/2021
1	Surgical Instruments (Clip) 11/2021
1	Central Venous Catheters 03/2020
1	Diet Therapy (Therapy, Diet) 12/2019
1	Gastrectomy 01/2018
1	Colectomy 01/2018
1	Pancreatectomy 12/2017
1	Transjugular Intrahepatic Portasystemic Shunt 04/2017